NU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL
NDC 62032-533, Hydroquinone, Homosalate, Octisalate, and Zinc Oxide, kit, from OBAGI COSMECEUTICAL LLC.
- Product NDC
- 62032-533
- Status
- Listed
- Labeler
- OBAGI COSMECEUTICAL LLC
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62032-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62032-533-60 | 62032053360 | 1 KIT in 1 KIT (62032-533-60) * 59 mL in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/48a6f977-d7b8-4da4-8bab-b3b8df5347c3
Use it
Look up 62032-533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62032-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62032-533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.